Jeena Sikho Lifecare (NSE:JSLL) ROCE %: 45.64% (As of Mar. 2026)


NSE:JSLL Jeena Sikho Lifecare Ltd NSE:JSLL
91 GF Score
Price ₹602.25
GF Value ₹771.14
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Jeena Sikho Lifecare ROCE %?

Jeena Sikho Lifecare NSE:JSLL +3.81% 91 ROCE % is 45.64% as of Mar. 2026. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹771.14 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Jeena Sikho Lifecare's annualized ROCE % for the quarter that ended in Mar. 2026 was 45.64%.


Jeena Sikho Lifecare  (NSE:JSLL) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Jeena Sikho Lifecare ROCE % Related Terms


Jeena Sikho Lifecare ROCE % Historical Data

* Premium members only.

The historical data trend for Jeena Sikho Lifecare's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jeena Sikho Lifecare ROCE % Chart

Jeena Sikho Lifecare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial 51.83 54.94 58.82 50.40 73.40

Jeena Sikho Lifecare Quarterly Data
Mar19 Mar20 Mar21 Sep21 Mar22 Mar23 Mar24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.63 101.68 75.78 83.96 45.64
NSE:JSLL
91GF Score
Jeena Sikho Lifecare Ltd NSE:JSLL
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jeena Sikho Lifecare ROCE % Calculation

Jeena Sikho Lifecare's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=3102.27/( ( (3283.056 - 522.688) + (6742.416 - 1049.849) )/ 2 )
=3102.27/( (2760.368+5692.567)/ 2 )
=3102.27/4226.4675
=73.40 %

Jeena Sikho Lifecare's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=2598.124/( ( (0 - 0) + (6742.416 - 1049.849) )/ 1 )
=2598.124/( ( 0 + 5692.567 )/ 1 )
=2598.124/5692.567
=45.64 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 45.64% mean?
Jeena Sikho Lifecare (NSE:JSLL) has a ROCE % of 45.64% as of Mar. 2026.
Is Jeena Sikho Lifecare's ROCE % too high?
Jeena Sikho Lifecare's current ROCE % is 45.64%. The Healthcare Providers & Services industry median ROCE % is 6.41. Jeena Sikho Lifecare's value of 45.64% is 612% above this industry median. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's ROCE % compare to HCA and THC?
Jeena Sikho Lifecare's ROCE % of 45.64% can be compared against companies in the Healthcare Providers & Services industry. The industry median ROCE % is 6.41. Jeena Sikho Lifecare's value of 45.64% is 612% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Healthcare Providers & Services company?
The median ROCE % among Healthcare Providers & Services companies is 6.41, based on 648 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current ROCE % of 45.64% is 612% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Healthcare Providers & Services industry, the median ROCE % is 6.41 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current ROCE % is 45.64%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.14, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current ROCE % is 45.64% and 612% above the Healthcare Providers & Services industry median of 6.41. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current ROCE % is 45.64% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?

Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued. The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.14. GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.

Key valuation signals for NSE:JSLL:

  • ROCE %: 45.64%
  • GF Value™: ₹771.14 vs. price of ₹602.25 (21.9% below fair value)
  • GF Score™: 91/100 with 3 warning signs
  • Industry Position: 612% above the Healthcare Providers & Services median

No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Jeena Sikho Lifecare Business Description

Other Exchanges 544476:India
Address Kalgidhar Enclave, SCO 11 First Floor, Mohali, Zirakpur, PB, IND, 140604
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score

Get the complete analysis for NSE:JSLL

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹602.25
Price
₹771.14
GF Value